Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 35, Issue 8, 2008, Pages 1680-1681

  Yildirim Toruner, Cagri ^a   Kimura, Yukiko ^b   Rabinovich, C Egla ^c  

^a UMDNJ New Jersey Medical School

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTINEOPLASTIC AGENT; BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; ETANERCEPT; IBUPROFEN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VINCRISTINE;

ABDOMINAL PAIN; ANAPHYLAXIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; COMBINATION CHEMOTHERAPY; COUGHING; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JUVENILE RHEUMATOID ARTHRITIS; LETTER; LOW DRUG DOSE; MALE; NIGHT SWEAT; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SIDE EFFECT; THORAX PAIN; UVEITIS; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49049111571     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671-84.
2. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85.
3. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:265-7.
4. Londino AV Jr, Blatt J, Knisely AS. Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate. J Rheumatol 1998;25:1245-6.
5. Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol 1997;24:2035-7.
6. Takeyama J, Sato A, Nakano K, Abukawa D, Ichinohazama R, Imaizumi M. Epstein-Barr virus associated Hodgkin lymphoma in a 9-year-old girl receiving long-term methotrexate therapy for juvenile idiopathic arthritis. J Pediatr Hematol Oncol 2006;28:622-4.
7. Cleary AG, McDowell H, Sills JA. Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child 2002;86:47-9.
8. Yildirim Y. Primary ovarian large B-cell lymphoma in a patient with juvenile rheumatoid arthritis treated with low dose methotrexate. Gynecol Oncol 2005;97:249-52.
9. Lovell DJ, Reiff A, Jones OY, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:1987-94.
10. Imundo L. Hodgkin's lymphoma associated with anti-tumor necrosis factor use in juvenile idiopathic arthritis: Supplemental case report [letter]. J Rheumatol 2008;35:1681-2.